Portfolio company news

All Group media enquiries should be directed to
Vanessa Maydon, Corporate Affairs Director.

Cinven Partners LLP
Warwick Court
Paternoster Square
London EC4M 7AG

 

Tel: +44 (0)20 7661 3325
Mob: +44 (0)7802 961 902
Email: Vanessa Maydon

Press releases

Bioclinica
20 October 2016

Cinven completes acquisition of Bioclinica

Cinven has today completed the acquisition of Bioclinica, a global provider of clinical trial services and technology to contract research organisations (CROs) and pharmaceutical companies, for an undisclosed consideration.

Cinven's healthcare team identified Bioclinica as a compelling investment opportunity given the team's strong track record in the clinical trials sector and direct experience through its investment in Medpace, a leading CRO business. Bioclinica operates in a number of high growth areas to improve the efficiency and productivity of clinical trials. Bioclinica benefits from structural factors including as growing clinical trial activity, increased outsourcing and the adoption of clinical software services.

Bioclinica represents the first investment from Cinven's sixth fund.